The Cooper Companies (COO) traded 9.6 million shares against a thirty-day average of 1.8 million shares — 5.4 times its own norm, or $607m changing hands. The price fell 6.2% to $63.48.
The price now sits near the bottom of its twelve-month band of $58.98 to $84.32, only 18% up from the floor. That floor was printed 87 sessions ago on May 11, 2026; the peak is further back, January 6, 2026, 176 sessions ago.
The stock is down 9.0% over five sessions, down 16.8% over a month, down 6.0% over the year. It closed below its thirty-day average price by 13.6%.
High to low, the session covered 8.9% of price — well beyond the 2.0% this stock averages over thirty sessions. The close gave most of it back, settling only 22% up the day's range. It was the 2nd session running lower.
Worth $14bn, the company sits 70 of 128 by size within healthcare. The sector as a whole finished -0.4%, leaning the same way.
From an open of $67.07 the price ranged down to $62.24 and up to $67.92 before closing on $63.48. That is 7.6% above the year's $58.98 floor and 24.7% under its $84.32 ceiling.
Turnover of $607m compares with $112m on an average session for this stock, so participation was well above its own norm. Against the year, today ranks between the +8.6% best and the -6.2% worst day.
Recent form has been the other way, 17 of the last thirty sessions closing down against 12 up. Its strongest single day in the past year was +8.6% on June 5, 2026, its weakest -6.2% on September 9, 2026.
Its size-neighbours in the sector did not follow — Baxter International (BAX) -1.9% and Exelixis (EXEL) +1.1% — which argues for something particular to this company. COO placed 169th of 986 on money traded.
This text was generated automatically from the closing data. It contains no forecasts and no investment advice — only what the numbers say. Do your own research.